Contact this trialFirst, we need to learn more about you.
Radiation
Durvalumab + Radiotherapy for Oral Cancer
Recruiting1 awardPhase 2
Charleston, South Carolina
This trial is investigating whether adding the experimental drug durvalumab to radiation therapy can improve cure rates and reduce side effects for people with head and neck cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service